References
The End of Alzheimer’s Program – Dale E. Bredesen, M.D. References
Following is a list of references from the book, The End of Alzheimer’s Program, published by Avery/Random House. Due to the length of the text, these references could not be included in the print version, and therefore are listed below.
18 – Aristo Vojdani, Alternative Therapies in Health and Medicine 21, supplement 1, 34–45, January 2015
Molecular Mimicry as a Mechanism for Food Immune Reactivities and Autoimmunity
19 – Ruth Bollongino et al., Molecular Biology and Evolution 29, no. 9, 2101–04, September 2012
Modern Taurine Cattle Descended from Small Number of Near-Eastern Founders
20 – Linni Kral, The Atlantic, January 27, 2017
The Health Battle Behind America’s Next Milk Trend
21 – Monika Sodhi et al., Indian Journal of Endocrinology and Metabolism 16, no. 5, 856, September–October 2012
Milk Proteins and Human Health: A1/A2 Milk Hypothesis
22 – Robert Bartlett Elliot et al., Diabetologia 42, no. 3, 292–96, April 1999
Type I (Insulin-Dependent) Diabetes Mellitus and Cow Milk: Casein Variant Consumption
22 – C. N. S. McLachlan, Medical Hypotheses 56, no. 2, 262–72, March 2001
β-Casein A1, Ischaemic Heart Disease Mortality, and Other Illnesses
23 – Sun Jianqin et al., Nutrition Journal 15, 35, April 2016
Effects of Milk Containing Only A2 Beta Casein Versus Milk Containing Both A1 and A2 Beta Casein Proteins on Gastrointestinal Physiology, Symptoms of Discomfort, and Cognitive Behavior of People with Self-Reported Intolerance to Traditional Cows’ Milk
23 – B. R. Kadam et al., Journal of Environment and Bio-Sciences 31, no. 2, 357–62, December 2017
A1/A2 Milk and Human Health: A Brief Review
24 – Simon Brooke-Taylor et al., Advances in Nutrition 8, no. 5, 739–48, September 2017
Systematic Review of the Gastrointestinal Effects of A1 Compared with A2 β-Casein
25 – Eunyoung Cho et al., Journal of the National Cancer Institute 95, no. 14, 1079–85, August 2003